FRANKFURT (Reuters) – Shares in kidney dialysis group Fresenius Medical Care declined 1.7% at market open in Germany on Tuesday after a payment increase proposed by a major U.S. public health insurance body fell short of market expectations.
Analysts said the base-rate payment increase proposed by the Centers for Medicare & Medicaid Services late on Monday was 1.6% to 1.7% lower than projected.
(Reporting by Ludwig Burger; Editing by Maria Sheahan)
